The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

The US Food and Drug Administration (FDA) has removed the clinical hold on the Investigational New Drug (IND) application for ...

The firm said the FDA lifted its clinical hold on its COVID/flu combo and standalone flu vaccine resuming plans to initiate Ph3 imminently. Q3 COVID vaccine revenues missed as expected, given delayed ...

In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

The information provided to the FDA supported our assessment that the serious adverse ... Novavax seasonal influenza vaccine ...

China has reported seven more H9N2 avian flu infections in humans, mostly involving children and all in people whose symptoms ...

The FDA concluded that the event was not related to the vaccine. Robert Walker ... China has reported seven more H9N2 avian ...

AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Across California, public health and pest control authorities are facing a new reality as the Aedes mosquitoes bring the ...

Flu and COVID-19 shots are available by appointment at BCHD ... for whom it is still being given under Emergency Use Authorization from the FDA, the vaccine decreases the risk of hospitalization and ...

SAN DIEGO, CA, USA I November 11, 2024 I Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines ...